Paper178275
In vivo synergy between 6 beta-amidinopenicillanic acid derivatives and other antibiotics.
Grunberg E and 3 others. Antimicrob Agents Chemother, 1976. Cited by 69 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. In vivo synergy between 6 beta-amidinopenicillanic acid derivatives and other antibiotics. Papers, record 178275. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/178275
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vivo synergy between 6 beta-amidinopenicillanic acid derivatives and other antibiotics.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Bacteria | Major topic |
| Penicillanic Acid | Major topic |
| Animals | |
| Bacterial Infections | |
| Drug Synergism | |
| Mice |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,590,478 | Mechanism of action and development of resistance to a new amidino penicillin. | J Bacteriol | 1974 | https://conductscience.org/library/papers/4590478 | PubMed |
| 2 | 4,758,061 | Trimethoprim-sulfamethoxazole. Summary and comments on the conference. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4758061 | PubMed |
| 3 | 1,157,572 | Pharmacokinetic studies with mecillinam and pivmecillinam. | Chemotherapy | 1975 | https://conductscience.org/library/papers/1157572 | PubMed |
| 4 | 168,179 | Inhibition of an early event in the cell division cycle of Escherichia coli by FL1060, an amidinopenicillanic acid. | J Bacteriol | 1975 | https://conductscience.org/library/papers/168179 | PubMed |
| 5 | 170,856 | Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: bactericidal action and synergy in vitro. | Antimicrob Agents Chemother | 1975 | https://conductscience.org/library/papers/170856 | PubMed |
| 6 | 4,348,402 | FL 1060: a new beta-lactam antibiotic with novel properties. | J Clin Pathol | 1973 | https://conductscience.org/library/papers/4348402 | PubMed |
| 7 | 4,358,124 | The two sites of penicillin action in Escherichia coli. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4358124 | PubMed |
| 8 | 4,402,006 | 6 -amidinopenicillanic acids--a new group of antibiotics. | Nat New Biol | 1972 | https://conductscience.org/library/papers/4402006 | PubMed |
| 9 | 4,574,155 | FL-1060: a new penicillin with a unique mode of action. | Biochem Biophys Res Commun | 1973 | https://conductscience.org/library/papers/4574155 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,423,179 | Combinations of beta lactam antibiotics. | Br Med J (Clin Res Ed) | 1984 | https://conductscience.org/library/papers/6423179 | PubMed |
| 6,289,730 | Treatment of experimental Salmonella typhimurium infection with mecillinam and ampicillin. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6289730 | PubMed |
| 6,284,652 | Mecillinam alone and in combination with ampicillin or moxalactam in experimental Escherichia coli meningitis. | Infection | 1982 | https://conductscience.org/library/papers/6284652 | PubMed |
| 6,280,596 | Induction of cell lysis in Escherichia coli: cooperative effect of nocardicin A and mecillinam. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6280596 | PubMed |
| 6,277,795 | Inhibitory activity and bactericidal kinetics of mecillinam/ampicillin combinations against Enterobacteriaceae, Pseudomonas and Acinetobacter. | Infection | 1981 | https://conductscience.org/library/papers/6277795 | PubMed |
| 6,263,179 | Activity of mecillinam alone and in combination with other beta-lactam antibiotics. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6263179 | PubMed |
| 6,252,835 | Carbenicillin plus cefazolin with or without mecillinam as an early treatment of bacteremia caused by gram-negative organisms: randomized double-blind study. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6252835 | PubMed |
| 6,246,005 | Pivmecillinam in the treatment of therapy resistant urinary tract infections. A comparison with pivmecillinam, pivampicillin and their combination. | Infection | 1980 | https://conductscience.org/library/papers/6246005 | PubMed |
| 3,494,745 | Influence of growth medium and supplement on growth of Haemophilus influenzae and on antibacterial activity of several antibiotics. | J Clin Microbiol | 1987 | https://conductscience.org/library/papers/3494745 | PubMed |
| 3,377,469 | Influence of food on bioavailability of amdinocillin pivoxil. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/3377469 | PubMed |
| 3,069,197 | Haemophilus influenzae: antibiotic susceptibility. | Clin Microbiol Rev | 1988 | https://conductscience.org/library/papers/3069197 | PubMed |
| 1,267,442 | Synergy of mecillinam (FL1060) with penicillins and cephalosporins against Proteus and Klebsiella, with observations on combinations with other antibiotics and against other bacterial species. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/1267442 | PubMed |
| 984,795 | Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibiotics. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/984795 | PubMed |
| 228,591 | Mecillinam-ampicillin synergism in experimental Enterobacteriaceae meningitis. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/228591 | PubMed |
| 193,439 | Comparison of the effects of mecillinam and 6-aminopenicillanic acid on Proteus mirabilis, Escherichia coli, and Staphylococcus aureus. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/193439 | PubMed |
| 189,683 | Comparison of the binding properties of two 6 beta-amidinopenicillanic acid derivatives that differ in their physiological effects on Escherichia coli. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/189683 | PubMed |
| 43,113 | Phosphonopeptides as antibacterial agents: alaphosphin and related phosphonopeptides. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/43113 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/178275
GET https://conductscience.org/api/papers/v1/178275/authors